166 related articles for article (PubMed ID: 8408658)
1. Vasonatrin peptide: a unique synthetic natriuretic and vasorelaxing peptide.
Wei CM; Kim CH; Miller VM; Burnett JC
J Clin Invest; 1993 Oct; 92(4):2048-52. PubMed ID: 8408658
[TBL] [Abstract][Full Text] [Related]
2. Atrial natriuretic peptide and C-type natriuretic peptide in spontaneously hypertensive rats and their vasorelaxing actions in vitro.
Wei CM; Kim CH; Khraibi AA; Miller VM; Burnett JC
Hypertension; 1994 Jun; 23(6 Pt 2):903-7. PubMed ID: 8206626
[TBL] [Abstract][Full Text] [Related]
3. [Comparison of vasorelaxing actions of vasonatrin peptide, C-type natriuretic peptide and atrial natriuretic peptide].
Feng HS; Zang YM; Zhu MZ; Pei JM; Wang YM; Wang L; Shi PT
Sheng Li Xue Bao; 1999 Oct; 51(5):515-20. PubMed ID: 11498948
[TBL] [Abstract][Full Text] [Related]
4. Receptor subtypes for vasonatrin peptide in renal glomeruli and arteries.
Woodard GE; Li X; Brown J; Rosado JA
Regul Pept; 2005 Jul; 129(1-3):183-9. PubMed ID: 15927715
[TBL] [Abstract][Full Text] [Related]
5. Action of C-type natriuretic peptide in isolated canine arteries and veins.
Wei CM; Aarhus LL; Miller VM; Burnett JC
Am J Physiol; 1993 Jan; 264(1 Pt 2):H71-3. PubMed ID: 8430863
[TBL] [Abstract][Full Text] [Related]
6. The effects of vasonatrin peptide on random pattern skin flap survival.
Wang SP; Lan ZY; Xia W; Zhao X; Ma GJ; Liu B; Pan BH; Guo SZ
Ann Plast Surg; 2014 Jan; 72(1):94-9. PubMed ID: 23403542
[TBL] [Abstract][Full Text] [Related]
7. AC-NP: a novel chimeric peptide with natriuretic and vasorelaxing actions.
Chen BY; Chen JK; Zhu MZ; Zhang DL; Sun JS; Pei JM; Feng HS; Zhu XX; Jin J; Yu J
PLoS One; 2011; 6(5):e20477. PubMed ID: 21647224
[TBL] [Abstract][Full Text] [Related]
8. C-type natriuretic peptide: a selective cardiovascular peptide.
Clavell AL; Stingo AJ; Wei CM; Heublein DM; Burnett JC
Am J Physiol; 1993 Feb; 264(2 Pt 2):R290-5. PubMed ID: 8383462
[TBL] [Abstract][Full Text] [Related]
9. A new natriuretic peptide isolated from cardiac atria of trout, Oncorhynchus mykiss.
Takei Y; Fukuzawa A; Itahara Y; Watanabe TX; Yoshizawa Kumagaye K; Nakajima K; Yasuda A; Smith MP; Duff DW; Olson KR
FEBS Lett; 1997 Sep; 414(2):377-80. PubMed ID: 9315723
[TBL] [Abstract][Full Text] [Related]
10. Gender and relaxation to C-type natriuretic peptide in porcine coronary arteries.
Barber DA; Burnett JC; Fitzpatrick LA; Sieck GC; Miller VM
J Cardiovasc Pharmacol; 1998 Jul; 32(1):5-11. PubMed ID: 9676714
[TBL] [Abstract][Full Text] [Related]
11. Novel natriuretic peptide, CNP, potently stimulates cyclic GMP production in rat cultured vascular smooth muscle cells.
Furuya M; Takehisa M; Minamitake Y; Kitajima Y; Hayashi Y; Ohnuma N; Ishihara T; Minamino N; Kangawa K; Matsuo H
Biochem Biophys Res Commun; 1990 Jul; 170(1):201-8. PubMed ID: 2164803
[TBL] [Abstract][Full Text] [Related]
12. Relaxant effect of human brain natriuretic peptide on human artery and vein tissue.
Protter AA; Wallace AM; Ferraris VA; Weishaar RE
Am J Hypertens; 1996 May; 9(5):432-6. PubMed ID: 8735173
[TBL] [Abstract][Full Text] [Related]
13. Receptor proteins and biological effects of C-type natriuretic peptides in the renal glomerulus of the rat.
Brown J; Zuo Z
Am J Physiol; 1994 Apr; 266(4 Pt 2):R1383-94. PubMed ID: 8184983
[TBL] [Abstract][Full Text] [Related]
14. The natriuretic peptide system in the brain: implications in the central control of cardiovascular and neuroendocrine functions.
Imura H; Nakao K; Itoh H
Front Neuroendocrinol; 1992 Jul; 13(3):217-49. PubMed ID: 1334000
[TBL] [Abstract][Full Text] [Related]
15. Vascular natriuretic peptide receptor-linked particulate guanylate cyclases are modulated by nitric oxide-cyclic GMP signalling.
Madhani M; Scotland RS; MacAllister RJ; Hobbs AJ
Br J Pharmacol; 2003 Aug; 139(7):1289-96. PubMed ID: 12890708
[TBL] [Abstract][Full Text] [Related]
16. [Structure and function of ventricular natriuretic peptide (VNP)].
Takei Y
Nihon Rinsho; 1992 Mar; 50(3):656-63. PubMed ID: 1534127
[TBL] [Abstract][Full Text] [Related]
17. The role of the C-terminal region of rat brain natriuretic peptide in receptor selectivity.
Shimekake Y; Kawabata T; Nakamura M; Nagata K
FEBS Lett; 1992 Sep; 309(2):185-9. PubMed ID: 1324196
[TBL] [Abstract][Full Text] [Related]
18. [Comparison of inhibitory effects of three natriuretic peptides on the proliferation of pulmonary artery smooth muscle cells of rats].
Dong MQ; Zhu MZ; Yu J; Shang LJ; Feng HS
Sheng Li Xue Bao; 2000 Jun; 52(3):252-4. PubMed ID: 11956575
[TBL] [Abstract][Full Text] [Related]
19. Bioactivity and metabolism of C-type natriuretic peptide in normal man.
Hunt PJ; Richards AM; Espiner EA; Nicholls MG; Yandle TG
J Clin Endocrinol Metab; 1994 Jun; 78(6):1428-35. PubMed ID: 8200946
[TBL] [Abstract][Full Text] [Related]
20. Relationship between the suppressive actions on intestinal absorption and on cGMP production for the natriuretic peptide family in dogs.
Kagawa K; Suzuki S; Matsushita K; Uemura N; Morita H; Hosomi H
Clin Exp Pharmacol Physiol; 1994 Feb; 21(2):83-92. PubMed ID: 8039275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
